CEOs in any industry face certain challenges around innovating. In biotechnology, these problems can lead to projects being stalled, original plans being scrapped, and even nothing to show for it in ...

As AI becomes more embedded in biotech R&D, companies are competing for professionals who can bridge biology, machine ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting its extraordinary biodiversity. Food security has become a pressing concern ...

HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax-efficient and more volatile. Active management and venture capital-style investing add ...